FTC breast enhancement case
This article was originally published in The Tan Sheet
Executive Summary
J. Michael Ernest, PhD, Isis Breast Enhancement System developer, agrees to settle FTC charges he made deceptive statements in print, radio, TV, Internet ads for the supplement/topical cream combo, commission says Jan. 22. Proposed stipulated final order requires Ernest to "have competent and reliable scientific evidence" before making any claims about Isis, other products. Settlement follows recent case brought by FTC against Isis marketer Vital Dynamics, which was settled in December (1"The Tan Sheet" Jan. 6, 2003, p. 19)...
You may also be interested in...
Isis Breast Enhancement System Safety, Efficacy Questioned By FTC
Vital Dynamics promoted its Isis Breast Enhancement System as free of side effects after receiving "hundreds of reports of negative side effects," according to a Federal Trade Commission complaint
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.